References and Further Reading
Anlauf, M., Schlenger, R., Perren, A., et al. (2006). Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome. The American Journal of Surgical Pathology, 30, 560–574.
Lubensky, I. A., Pack, S., Ault, D., et al. (1998). Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: Histopathological and molecular genetic analysis. The American Journal of Pathology, 153, 223–231.
Lucas, M., Yu, V., & Yu, R. (2013). Mahvash disease: Pancreatic neuroendocrine tumor syndrome caused by inactivating glucagon receptor mutation. Journal of Molecular and Genetic Medicine, 7, 4.
Sipos, B., Sperveslage, J., Anlauf, M., et al. (2015). Glucagon cell hyperplasia and neoplasia with and without glucagon receptor mutations. The Journal of Clinical Endocrinology and Metabolism, 100, E783–E788.
Solloway, M. J., Madjidi, A., Gu, C., et al. (2015). Glucagon couples hepatic amino acid catabolism to mTOR-dependent regulation of alpha-cell mass. Cell Reports, 12, 495–510.
Yu, R., Nissen, N. N., Dhall, D., et al. (2008). Nesidioblastosis and hyperplasia of alpha cells, microglucagonoma, and nonfunctioning islet cell tumor of the pancreas: Review of the literature. Pancreas, 36, 428–431.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Hackeng, W.M., Luchini, C., Brosens, L.A. (2020). Glucagon Cell Hyperplasia and Neoplasia. In: van Krieken, J. (eds) Encyclopedia of Pathology. Encyclopedia of Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-28845-1_5509-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-28845-1_5509-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-28845-1
Online ISBN: 978-3-319-28845-1
eBook Packages: Springer Reference MedicineReference Module Medicine